Functional Status, Pulmonary Artery Pressure, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction

Journal of the American College of Cardiology

Volumn 68, Issue 2, 2016, Pages 189-199

  Dalos, Daniel ^a   Mascherbauer, Julia ^a   Zotter Tufaro, Caroline ^a   Duca, Franz ^a   Kammerlander, Andreas A ^a   Aschauer, Stefan ^a   Bonderman, Diana ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

functional capacity; heart failure; outcome

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN;

AGE; AGED; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CLINICAL OUTCOME; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC PULMONARY ARTERY PRESSURE; DISEASE ASSOCIATION; EARLY DIASTOLIC MITRAL ANNULAR VELOCITY; EARLY MITRAL INFLOW VELOCITY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART DEATH; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE ENDDIASTOLIC DIAMETER; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MITRAL PEAK VELOCITY OF LATE FILLING; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TRICUSPID ANNULAR PLANE SYSTOLIC EXCURSION; BLOOD FLOW VELOCITY; BLOOD PRESSURE; DIAGNOSTIC IMAGING; DIASTOLE; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART FAILURE; HEART STROKE VOLUME; HEART VENTRICLE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; PULMONARY ARTERY; QUALITY OF LIFE; TIME FACTOR;

AGED; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CARDIAC CATHETERIZATION; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY ARTERY; QUALITY OF LIFE; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84990193931     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.04.052     Document Type: Article

References (43)

1. 1 Hogg, K., Swedberg, K., McMurray, J., Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 43 (2004), 317–327.
2. 2 Bhatia, R.S., Tu, J.V., Lee, D.S., et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355 (2006), 260–269.
3. 3 Smith, G.L., Masoudi, F.A., Vaccarino, V., et al. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol 41 (2003), 1510–1518.
4. 4 Zile, M.R., Baicu, C.F., Gaasch, W.H., Diastolic heart failure—abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 350 (2004), 1953–1959.
5. 5 Zile, M.R., Baicu, C.F., Ikonomidis, J.S., et al. Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin. Circulation 131 (2015), 1247–1259.
6. 6 Martos, R., Baugh, J., Ledwidge, M., et al. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 115 (2007), 888–895.
7. 7 Mascherbauer, J., Marzluf, B.A., Tufaro, C., et al. Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction. Circ Cardiovasc Imaging 6 (2013), 1056–1065.
8. 8 Upadhya, B., Haykowsky, M.J., Eggebeen, J., Kitzman, D.W., Exercise intolerance in heart failure with preserved ejection fraction: more than a heart problem. J Geriatr Cardiol 12 (2015), 294–304.
9. 9 Drazner, M.H., Hellkamp, A.S., Leier, C.V., et al. Value of clinician assessment of hemodynamics in advanced heart failure: the ESCAPE trial. Circ Heart Fail 1 (2008), 170–177.
10. 10 Solomonica, A., Burger, A.J., Aronson, D., Hemodynamic determinants of dyspnea improvement in acute decompensated heart failure. Circ Heart Fail 6 (2013), 53–60.
11. 11 Goliasch, G., Zotter-Tufaro, C., Aschauer, S., et al. Outcome in heart failure with preserved ejection fraction: the role of myocardial structure and right ventricular performance. PLoS One, 10, 2015, e0134479.
12. 12 Melenovsky, V., Hwang, S.J., Lin, G., Redfield, M.M., Borlaug, B.A., Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J 35 (2014), 3452–3462.
13. 13 Mohammed, S.F., Hussain, I., AbouEzzeddine, O.F., et al. Right ventricular function in heart failure with preserved ejection fraction: a community-based study. Circulation 130 (2014), 2310–2320.
14. 14 Aschauer, S., Kammerlander, A.A., Zotter-Tufaro, C., et al. The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics. Eur J Heart Fail 18 (2016), 71–80.
15. 15 Mentz, R.J., Kelly, J.P., von Lueder, T.G., et al. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol 64 (2014), 2281–2293.
16. 16 Ather, S., Chan, W., Bozkurt, B., et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved ejection fraction. J Am Coll Cardiol 59 (2012), 998–1005.
17. 17 Raphael, C., Briscoe, C., Davies, J., et al. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart 93 (2007), 476–482.
18. 18 Paulus, W.J., Tschope, C., Sanderson, J.E., et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28 (2007), 2539–2550.
19. 19 Yancy, C.W., Jessup, M., Bozkurt, B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62 (2013), e147–e239.
20. 20 The Criteria Committee of the New York Heart Associaton. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th revised edition, 1994, Little, Brown, Boston, MA, 253–256.
21. 21 Lang, R.M., Bierig, M., Devereux, R.B., et al. Recommendations for chamber quantification. Eur J Echocardiogr 7 (2006), 79–108.
22. 22 Hoeper, M.M., Lee, S.H., Voswinckel, R., et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 48 (2006), 2546–2552.
23. 23 Madsen, B.K., Hansen, J.F., Stokholm, K.H., et al. Chronic congestive heart failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms. Eur Heart J 15 (1994), 303–310.
24. 24 O'Connor, C.M., Gattis, W.A., Shaw, L., et al. Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function. Am J Cardiol 86 (2000), 863–867.
25. 25 Ahmed, A., Aronow, W.S., Fleg, J.L., Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function. Am Heart J 151 (2006), 444–450.
26. 26 Borlaug, B.A., Jaber, W.A., Ommen, S.R., Lam, C.S., Redfield, M.M., Nishimura, R.A., Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction. Heart 97 (2011), 964–969.
27. 27 Borlaug, B.A., Nishimura, R.A., Sorajja, P., et al. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 3 (2010), 588–595.
28. 28 Maeder, M.T., Thompson, B.R., Htun, N., Kaye, D.M., Hemodynamic determinants of the abnormal cardiopulmonary exercise response in heart failure with preserved left ventricular ejection fraction. J Cardiac Fail 18 (2012), 702–710.
29. 29 Gerges, C., Gerges, M., Lang, M.B., et al. Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in “out-of-proportion” pulmonary hypertension. Chest 143 (2013), 758–766.
30. 30 Zotter-Tufaro, C., Duca, F., Kammerlander, A.A., et al. Diastolic pressure gradient predicts outcome in patients with heart failure and preserved ejection fraction. J Am Coll Cardiol 66 (2015), 1308–1310.
31. 31 Guazzi, M., Pulmonary hypertension in heart failure preserved ejection fraction: prevalence, pathophysiology, and clinical perspectives. Circ Heart Fail 7 (2014), 367–377.
32. 32 Lip, G.Y., Laroche, C., Popescu, M.I., et al. Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation. Eur J Heart Fail 17 (2015), 570–582.
33. 33 Haass, M., Kitzman, D.W., Anand, I.S., et al. Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail 4 (2011), 324–331.
34. 34 Kitzman, D.W., Brubaker, P., Morgan, T., et al. Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 315 (2016), 36–46.
35. 35 Haykowsky, M.J., Kouba, E.J., Brubaker, P.H., et al. Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fraction. Am J Cardiol 113 (2014), 1211–1216.
36. 36 Civitarese, A.E., Carling, S., Heilbronn, L.K., et al. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med, 4, 2007, e76.
37. 37 Paulus, J., Tschöpe, C., A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62 (2013), 263–271.
38. 38 Mohammed, S.F., Hussain, S., Mirzoyev, S.A., et al. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction. Circulation 131 (2015), 550–559.
39. 39 Kitzman, D.W., Nicklas, B., Kraus, W.E., et al. Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction. Am J Physiol Heart Circ Physiol 306 (2014), 1364–1370.
40. 40 Haykowsky, M.J., Brubaker, P.H., John, J.M., et al. Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. J Am Coll Cardiol 58 (2011), 265–274.
41. 41 Dhakal, B.P., Malhotra, R., Murphy, R.M., et al. Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction. Circ Heart Fail 8 (2015), 286–294.
42. 42 Bowen, T.S., Rolim, N.P., Fischer, T., et al. Heart failure with preserved ejection fraction induces molecula, mitochondrial, histological, and functional alterations in rat respiratory and limb skeletal muscle. Eur J Heart Fail 17 (2015), 263–272.
43. 43 Hundley, W.G., Kitzman, D.W., Morgan, T.M., et al. Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol 38 (2011), 796–802.